Arrowhead Pharmaceuticals
ARWR
#2242
Rank
โ‚น795.38 B
Marketcap
โ‚น5,680
Share price
-2.91%
Change (1 day)
225.83%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total debt

Total debt on the balance sheet as of December 2025 : โ‚น28.36 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total debt is โ‚น28.36 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Arrowhead Pharmaceuticals - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2025-09-30โ‚น32.54 B-23.97%
2024-09-30โ‚น42.79 B346.76%
2023-09-30โ‚น9.57 B44.28%
2022-09-30โ‚น6.63 B250.05%
2021-09-30โ‚น1.89 B21.75%
2020-09-30โ‚น1.55 B
2019-09-30N/A-100%
2018-09-30โ‚น0.16 B1.88%
2017-09-30โ‚น0.16 B-9.25%
2016-09-30โ‚น0.18 B266.93%
2015-09-30โ‚น49.69 M-21.37%
2014-09-30โ‚น63.2 M-56.17%
2013-09-30โ‚น0.14 B11.97%
2012-09-30โ‚น0.12 B332.31%
2011-09-30โ‚น29.78 M33.69%
2010-09-30โ‚น22.28 M-61.95%
2009-09-30โ‚น58.55 M-18.19%
2008-09-30โ‚น71.57 M
2002-09-30โ‚น30.65 M14.57%
2001-09-30โ‚น26.75 M3.41%
2000-09-30โ‚น25.87 M5.19%
1999-09-30โ‚น24.59 M-45.88%
1998-09-30โ‚น45.45 M22.65%
1997-09-30โ‚น37.05 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚น4.152 T 14,541.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
โ‚น66.55 B 134.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น40.89 B 44.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น118.64 B 318.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
โ‚น0.90 B-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA